# Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)

> **NCT04654039** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 728 (actual)

## Conditions studied

- Infertility, Female

## Interventions

- **OTHER:** Other: Non intervention

## Key facts

- **NCT ID:** NCT04654039
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-26
- **Primary completion:** 2023-10-28
- **Final completion:** 2023-10-28
- **Target enrollment:** 728 (ACTUAL)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654039, "Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04654039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*